About the role#
Zymeworks is seeking a Co-op Student to join the Protein Engineering team in Vancouver. This is a full-time, on-site, paid position. You will support experimental studies focused on the purification and characterization of recombinant proteins. This role is designed to provide hands-on experience within a research environment.
What you'll do#
- Purify recombinant proteins using various chromatography techniques, such as affinity and size-exclusion.
- Characterize proteins using methods including SDS-PAGE, CE-SDS, UV-VIS spectrophotometry, and UPLC-SEC.
- Prepare necessary media, buffers, and reagents for laboratory experiments.
- Maintain accurate records of methods and raw data in electronic laboratory notebooks.
- Evaluate experimental data and summarize results for team presentations.
- Assist with routine laboratory maintenance and follow established safety and scientific protocols.
What you'll need#
- Current enrollment in an undergraduate program in Biochemistry, Immunology, Biology, or a related discipline.
- Availability for a co-op term of at least 8 months.
- Strong organizational skills and attention to detail.
- Ability to work collaboratively within a cross-functional team.
- Excellent oral and written communication skills.
- Experience with protein purification or biophysical characterization and knowledge of protein structure are considered assets.
Location & details#
- Location: Vancouver, British Columbia, Canada.
- Work Modality: On-site.
- Employment Type: Full-time.
- Compensation: $21.00 CAD per hour.
About Zymeworks Inc.
Founded in 2003 and headquartered in Vancouver, British Columbia, Zymeworks Inc. is a public biotechnology firm with 201 to 500 employees. The company focuses on the research and development of multispecific antibodies and antibody-drug conjugates to treat patients suffering from autoimmune diseases and complex cancers. Its operations utilize proprietary protein engineering platforms to create therapeutic solutions for conditions such as breast, gastric, and biliary tract cancers. Through an integrated research engine and various strategic partnerships, the organization manages a portfolio of biotherapeutics designed to address unmet medical needs.
